Search research articles
Contact Us
Filters
Showing results (121-130 of 232) with videos related to
Page
of 24
Sort By:
Leukemia
|
November 26, 2022
Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms
Gabrielle Paras, Megan Othus, Kelda Schonhoff, et al.
Leukemia & Lymphoma
|
October 3, 2018
A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study
Sarah A Buckley, Mary-Elizabeth Percival, Megan Othus, et al.
Blood Advances
|
October 5, 2024
Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia
Khushboo V Pal, Megan Othus, Zahra Ali, et al.
Blood Cancer Journal
|
January 14, 2024
Time independent factors that predict relapse in adults with acute myeloid leukemia
John J Lim, Megan Othus, Carole M Shaw, et al.
Cancer Immunology Research
|
June 8, 2026
Cancer chemo-immunotherapy: time will tell
Sam O Kleeman, Yosef Riazat-Kesh, Richard Carvajal, et al.
Cancer
|
June 25, 2009
Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery
Hale B Caglar, Elizabeth H Baldini, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 8, 2017
Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients
Olga Sala Torra, Megan Othus, David W Williamson, et al.
Leukemia
|
February 22, 2024
Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia
Daniel J Olivieri, Megan Othus, Corentin Orvain, et al.
Cancer
|
February 22, 2017
Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials
Xiaoyu Qu, Megan Othus, Jerry Davison, et al.
Cancer
|
September 25, 2014
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933
Sylvia M Lee, James Moon, Bruce G Redman, et al.
Page
of 24
Search research articles
Search
Showing results (121-130 of 232) with videos related to
Sort By:
Page
of 24
Leukemia
|
November 26, 2022
Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms
Gabrielle Paras, Megan Othus, Kelda Schonhoff, et al.
Leukemia & Lymphoma
|
October 3, 2018
A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study
Sarah A Buckley, Mary-Elizabeth Percival, Megan Othus, et al.
Blood Advances
|
October 5, 2024
Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia
Khushboo V Pal, Megan Othus, Zahra Ali, et al.
Blood Cancer Journal
|
January 14, 2024
Time independent factors that predict relapse in adults with acute myeloid leukemia
John J Lim, Megan Othus, Carole M Shaw, et al.
Cancer Immunology Research
|
June 8, 2026
Cancer chemo-immunotherapy: time will tell
Sam O Kleeman, Yosef Riazat-Kesh, Richard Carvajal, et al.
Cancer
|
June 25, 2009
Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery
Hale B Caglar, Elizabeth H Baldini, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 8, 2017
Next-Generation Sequencing in Adult B Cell Acute Lymphoblastic Leukemia Patients
Olga Sala Torra, Megan Othus, David W Williamson, et al.
Leukemia
|
February 22, 2024
Impact of socioeconomic disparities on outcomes in adults undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukemia
Daniel J Olivieri, Megan Othus, Corentin Orvain, et al.
Cancer
|
February 22, 2017
Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials
Xiaoyu Qu, Megan Othus, Jerry Davison, et al.
Cancer
|
September 25, 2014
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933
Sylvia M Lee, James Moon, Bruce G Redman, et al.
Page
of 24